CasNo.135046-48-9,Clopidogrel hydrogen sulfate,(135046-48-9) Suppliers

1 Metric Ton	Negotiable

Min.Order :1 Metric Ton
Purity: 99%
Payment Terms : T/T,

Keywords

SR-25990C PLAVIX CLOPIDOGREL BISULPHATE

Quick Details

Appearance:white power
Application:Medicine/Industria grade
PackAge:as your requirement
ProductionCapacity:1000|Metric Ton|Month
Storage:Keep it in dry,shady and cool place
Transportation:EMS、TNT、DHL、UPS、FEDEX、SF、Wuhan port/ Shanghai port / Guangzhou port/Tianjing port

Superiority:

1,we produce and sell good chemicals around the world.

2,our success rate is about 95%. this means, if customer order is accepted, the probability that the customer will obtain the ordered substances, is 95%.

3,our staff consists of highly qualified individuals with bsc, msc and ph.d degrees in chemistry, as well as excellent carbohydrates,nucleosides, small molecules and rare chemicals.

4,imaginechem's chemists are skilled at performing complex, multi-step syntheses and solving difficult chemistry-related problems. because of our better, concentracted size and low overheads, we are able to offer prompt quotations, very competitive prices, high quality products and fast delivery.

5,all chemicals are typically >97% for building blocks, the structure and purity is confirmed by nmr and lc-ms. intermediates and final products are analyzed by gc, hplc, ir, nmr, ms, elemental analysis, atom-absorpting analysis and crystallographical methods.

6,Customers-oriented strategy, exclusive supply chain management, professional R&D team, experienced production workers, energetic sales team enable us to offer best service andgood-value products to all of our customers and gradually reach our final goals: becoming global leading supplier for portable products and solutions.

Details:

Platelets play a central role in the pathogenesis of acute thrombotic cardiovascular and cerebrovascular events caused by atherosclerotic plaques.

Clopidogrel hydrogen sulfate is a kind of similar to chlorine pyridine away between the seconds of new antiplatelet aggregation drugs, by the French sanofi - fort SAN Della company research and development success, applicable to the prevention and treatment caused by high platelet aggregation of heart, brain and other artery circulation obstacle diseases, such as the recent onset of stroke, myocardial infarction, and diagnosis of patients with peripheral arterial disease. It has been widely used in many countries including the United States, Europe and China. This product inhibits platelet activation by inhibiting adenosine diphosphate (ADP) pathway, thereby inhibiting platelet aggregation. Clopidogrel bisulphate is not recommended for emergency treatment because it takes several days to reach an effective blood level. After 7 ~ 10 days, platelet function can be restored to normal state.